A detailed history of Bank Of America Corp transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 42,307 shares of CLPT stock, worth $788,179. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,307
Previous 13,565 211.88%
Holding current value
$788,179
Previous $152,000 327.63%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$10.74 - $16.68 $308,689 - $479,416
28,742 Added 211.88%
42,307 $650,000
Q3 2024

Nov 14, 2024

SELL
$5.3 - $13.18 $20,558 - $51,125
-3,879 Reduced 22.24%
13,565 $152,000
Q2 2024

Aug 14, 2024

BUY
$5.25 - $6.73 $26,680 - $34,201
5,082 Added 41.11%
17,444 $94,000
Q1 2024

May 15, 2024

SELL
$6.03 - $7.86 $140,993 - $183,782
-23,382 Reduced 65.42%
12,362 $84,000
Q4 2023

Feb 14, 2024

BUY
$4.46 - $7.07 $113,814 - $180,419
25,519 Added 249.57%
35,744 $242,000
Q2 2023

Aug 14, 2023

SELL
$6.54 - $10.58 $38,363 - $62,062
-5,866 Reduced 36.46%
10,225 $74,000
Q1 2023

May 12, 2023

BUY
$7.33 - $10.63 $87,498 - $126,890
11,937 Added 287.36%
16,091 $135,000
Q4 2022

Feb 10, 2023

SELL
$7.7 - $11.21 $7,422 - $10,806
-964 Reduced 18.84%
4,154 $35,000
Q3 2022

Nov 14, 2022

SELL
$9.82 - $16.49 $20,111 - $33,771
-2,048 Reduced 28.58%
5,118 $53,000
Q2 2022

Aug 12, 2022

SELL
$7.09 - $13.65 $62,023 - $119,410
-8,748 Reduced 54.97%
7,166 $93,000
Q1 2022

May 16, 2022

SELL
$7.8 - $11.6 $79,934 - $118,876
-10,248 Reduced 39.17%
15,914 $166,000
Q4 2021

Feb 08, 2022

BUY
$11.08 - $18.86 $186,188 - $316,923
16,804 Added 179.57%
26,162 $294,000
Q3 2021

Nov 15, 2021

BUY
$16.58 - $22.25 $6,648 - $8,922
401 Added 4.48%
9,358 $166,000
Q2 2021

Sep 13, 2021

BUY
$17.23 - $22.77 $154,329 - $203,950
8,957 New
8,957 $171,000

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $456M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.